Valeant Pharmaceuticals North America LLC recalls Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx
Recalled January 28, 2015 · FDA recall D-0379-2015 · Valeant Pharmaceuticals North America
Hazard
Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull. · FDA Class II
Units
2,428 vials
Sold at
Nationwide and Australia
Description
Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.
Product
Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.
Manufacturer(s)
Valeant Pharmaceuticals North America LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →